These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31062296)

  • 1. CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice.
    Petrov AM; Lam M; Mast N; Moon J; Li Y; Maxfield E; Pikuleva IA
    Neurotherapeutics; 2019 Jul; 16(3):710-724. PubMed ID: 31062296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease.
    Mast N; Saadane A; Valencia-Olvera A; Constans J; Maxfield E; Arakawa H; Li Y; Landreth G; Pikuleva IA
    Neuropharmacology; 2017 Sep; 123():465-476. PubMed ID: 28655608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment.
    Petrov AM; Mast N; Li Y; Pikuleva IA
    FASEB J; 2019 Aug; 33(8):8782-8798. PubMed ID: 31063705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Acetylcholine Levels and Other Brain Effects in 5XFAD Mice after Treatment with 8,14-Dihydroxy Metabolite of Efavirenz.
    Mast N; Li Y; Pikuleva IA
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP46A1-dependent and independent effects of efavirenz treatment.
    Mast N; El-Darzi N; Petrov AM; Li Y; Pikuleva IA
    Brain Commun; 2020; 2(2):fcaa180. PubMed ID: 33305262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7,8-Dihydroxy Efavirenz Is Not as Effective in CYP46A1 Activation In Vivo as Efavirenz or Its 8,14-Dihydroxy Metabolite.
    Mast N; Li Y; Pikuleva IA
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unbiased insights into the multiplicity of the CYP46A1 brain effects in 5XFAD mice treated with low dose-efavirenz.
    Mast N; Butts M; Pikuleva IA
    J Lipid Res; 2024 Jun; 65(6):100555. PubMed ID: 38719151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds.
    Mast N; Verwilst P; Wilkey CJ; Guengerich FP; Pikuleva IA
    J Med Chem; 2020 Jun; 63(12):6477-6488. PubMed ID: 31617715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease.
    Lerner AJ; Arnold SE; Maxfield E; Koenig A; Toth ME; Fortin B; Mast N; Trombetta BA; Denker J; Pieper AA; Tatsuoka C; Raghupathy S; Pikuleva IA
    Alzheimers Res Ther; 2022 Dec; 14(1):198. PubMed ID: 36581878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Therapeutic Targets for Brain Function and Disease.
    van Lier JE
    J Med Chem; 2020 Jun; 63(12):6474-6476. PubMed ID: 31845585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes.
    Petrov AM; Mast N; Li Y; Denker J; Pikuleva IA
    Brain Commun; 2020; 2(1):. PubMed ID: 32661514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.
    Petrov AM; Pikuleva IA
    Neurotherapeutics; 2019 Jul; 16(3):635-648. PubMed ID: 31001737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice.
    Mast N; Li Y; Linger M; Clark M; Wiseman J; Pikuleva IA
    J Biol Chem; 2014 Feb; 289(6):3529-38. PubMed ID: 24352658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Acetyl-CoA Production and Phosphorylation of Cytoskeletal Proteins Are Targets of CYP46A1 Activity Modulation and Altered Sterol Flux.
    Mast N; Petrov AM; Prendergast E; Bederman I; Pikuleva IA
    Neurotherapeutics; 2021 Jul; 18(3):2040-2060. PubMed ID: 34235635
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Mast N; Anderson KW; Johnson KM; Phan TTN; Guengerich FP; Pikuleva IA
    J Biol Chem; 2017 Aug; 292(31):12934-12946. PubMed ID: 28642370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice.
    Ali T; Hannaoui S; Nemani S; Tahir W; Zemlyankina I; Cherry P; Shim SY; Sim V; Schaetzl HM; Gilch S
    Acta Neuropathol Commun; 2021 Apr; 9(1):58. PubMed ID: 33795005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hydroxylation Position Rather than Chirality Determines How Efavirenz Metabolites Activate Cytochrome P450 46A1 In Vitro.
    Mast N; Fotinich A; Pikuleva IA
    Drug Metab Dispos; 2022 Jul; 50(7):923-930. PubMed ID: 35489779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity.
    Anderson KW; Mast N; Hudgens JW; Lin JB; Turko IV; Pikuleva IA
    J Biol Chem; 2016 May; 291(22):11876-86. PubMed ID: 27056331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1).
    Mast N; Lin JB; Anderson KW; Bjorkhem I; Pikuleva IA
    PLoS One; 2017; 12(10):e0187168. PubMed ID: 29073233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
    Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
    Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.